{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=ProRx%20LLC","name":"ProRx LLC","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-11-02T07:49:48.454Z"},"count":1,"matches":[{"id":"52abd3846174e32f","posted_date":"2026-05-12","letter_issue_date":"2026-04-07","company_name":"ProRx LLC","issuing_office":"Center for Drug Evaluation and Research (CDER)","subject":"Compounding Pharmacy/Adulterated Drug Products","canonical_url":"https://api.morvs.ai/fda-warning/52abd3846174e32f"}]}